Layton H. Smith - Concepedia

Author

Layton H. Smith

Sanford Burnham Prebys Medical Discovery Institute ORCID

Also Known As

Eigo Suyama, L H SMITH, L H Smith, L Harris Smith, L Smith, L. H. SMITH, L. H. Smith, L. Harris Smith, L. Smith, L.H. SMITH

305

Publications

4.4K

Citations

H-Index

152

Concepts

All Affiliations

Sanford Burnham Prebys Medical Discovery Institute Discovery Institute University of California San Diego Oak Ridge National Laboratory Vanderbilt University Medical Center

About

Layton H. Smith is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	42	2.3K
2	Natural Sciences	15	16	974
3	Health Sciences	8	8	449
4	Engineering	3	3	198
5	Social Sciences	1	1	39

Layton H. Smith

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Antidiabetic drug metformin (Glucophage <sup>R</sup> ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating <i>BACE1</i> transcription Yaomin Chen, Kun Zhou, Ruishan Wang, Proceedings of the National Academy of Sciences	2009	379
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2) Wooin Lee, Hartmut Glaeser, Layton H. Smith, Journal of Biological Chemistry Allelic VariantMolecular PhysiologyBiochemistryG Protein-coupled ReceptorDrug Disposition	2005	359
Effects of preezing on marrow stem cell suspensions: Interactions of cooling and warming rates in the presence of pvp, sucrose, or glycerol S.P. Leibo, J. Farrant, P. Mazur, Cryobiology MedicineStem Cell MobilizationHematologyStem Cell ResearchStem-cell Therapy	1970	246
APJ acts as a dual receptor in cardiac hypertrophy Maria Cecilia Scimia, Cecilia Hurtado, Saugata Ray, Nature Cardiac MuscleCardiomyopathyDual ReceptorSignal TransductionMolecular Physiology	2012	234
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11 Jing Li, Tanya Yakushi, Francesco Parlati, Nature Chemical Biology Specific InhibitorMolecular PharmacologyProtein ChemistryProtein FunctionProtein Assembly	2017	152
STABILITY OF THE KAPCHINSKIJ-VLADIMIRSKIJ (K-V) DISTRIBUTION IN LONG PERIODIC TRANSPORT SYSTEMS I. Hofmann, I. Haber, L.J. Laslett, CERN Bulletin EngineeringPhysicsThe Kapchinskij-vladimirskijKam TheoryTransport Phenomena	1983	132
Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates N <sup>ω</sup> -Nitro- <scp>l</scp> -Arginine Methyl Ester–Induced Hypertension and Vascular Senescence Amanda E. Boe, Mesut Eren, Sheila B. Murphy, Circulation	2013	129
Discovery and Validation of a Series of Aryl Sulfonamides as Selective Inhibitors of Tissue-Nonspecific Alkaline Phosphatase (TNAP) Russell Dahl, Eduard Sergienko, Ying Su, Journal of Medicinal Chemistry Selective InhibitorsLead SeriesChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2009	102
Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production Khandaker Siddiquee, Jessica Hampton, Susan Khan, Journal of Hypertension	2011	100
HNF4α Antagonists Discovered by a High-Throughput Screen for Modulators of the Human Insulin Promoter Alice Kiselyuk, Seung‐Hee Lee, Suzette Farber-Katz, Chemistry & Biology Molecular PharmacologyMolecular PhysiologyBiochemistryInsulin ManagementDiabetes	2012	86

Page 1